117 related articles for article (PubMed ID: 20408371)
1. [Metabolic syndrome: protective obesity].
Nau JY
Rev Med Suisse; 2010 Mar; 6(241):644-5. PubMed ID: 20408371
[No Abstract] [Full Text] [Related]
2. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
3. The metabolic syndrome: practical guide to origins and treatment: Part I.
Wilson PW; Grundy SM
Circulation; 2003 Sep; 108(12):1422-4. PubMed ID: 14504251
[No Abstract] [Full Text] [Related]
4. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome: is it a syndrome? Does it matter?
Kahn R
Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
[No Abstract] [Full Text] [Related]
6. Metabolic syndrome in overweight and obese Japanese children.
Yoshinaga M; Tanaka S; Shimago A; Sameshima K; Nishi J; Nomura Y; Kawano Y; Hashiguchi J; Ichiki T; Shimizu S
Obes Res; 2005 Jul; 13(7):1135-40. PubMed ID: 16076981
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hyperinsulinism, type 2 diabetes mellitus and metabolic syndrome among Saudi overweight and obese pediatric patients.
Al-Agha A; Ocheltree A; Shata N
Minerva Pediatr; 2012 Dec; 64(6):623-31. PubMed ID: 23108324
[TBL] [Abstract][Full Text] [Related]
8. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Haffner SM
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome: epidemiology and consequences.
Sacks FM
J Clin Psychiatry; 2004; 65 Suppl 18():3-12. PubMed ID: 15600380
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome and its cardiovascular manifestations.
Sánchez-Torres RJ; Delgado-Osorio H
Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
[TBL] [Abstract][Full Text] [Related]
11. gamma-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults.
Li M; Campbell S; McDermott R
Obesity (Silver Spring); 2009 Apr; 17(4):809-13. PubMed ID: 19148121
[TBL] [Abstract][Full Text] [Related]
12. Obesity and the metabolic syndrome in the elderly--a mini-review.
Lechleitner M
Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
[TBL] [Abstract][Full Text] [Related]
13. Obesity: a central risk and cardiovascular target of the cardiometabolic syndrome.
Frohlich ED
J Cardiometab Syndr; 2008; 3(3):147-8. PubMed ID: 18983330
[No Abstract] [Full Text] [Related]
14. Nutrition interventions for prevention of type 2 diabetes and the metabolic syndrome.
Pittas AG
Nutr Clin Care; 2003; 6(2):79-88. PubMed ID: 14692296
[TBL] [Abstract][Full Text] [Related]
15. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
Ballantyne CM
Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
[TBL] [Abstract][Full Text] [Related]
16. The medical cost of cardiometabolic risk factor clusters in the United States.
Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of the metabolic syndrome, 2002.
Meigs JB
Am J Manag Care; 2002 Sep; 8(11 Suppl):S283-92; quiz S293-6. PubMed ID: 12240700
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes for obesity and metabolic syndrome.
Vega GL
Obes Res; 2002 Nov; 10 Suppl 1():27S-32S. PubMed ID: 12446855
[No Abstract] [Full Text] [Related]
[Next] [New Search]